
    
      The study will include three arms: lidocaine, esmolol, and placebo. Eligible patients will be
      18-60 years old, ASA physical status 1-3, and scheduled for an elective surgical procedure.
      Patients will be randomized to receive lidocaine, esmolol, or placebo. Both the patients and
      the administering/observing providers will be blinded to the study drug or placebo being
      administered
    
  